arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CapsoVision, Inc

CV
$6.20 ▼ -0.68 (-9.95%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
3 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
10
Health
Poor
Bearish
auto_awesome

Analytical Summary

CapsoVision, Inc faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $152.2M
Dividend Yield —
Revenue Growth 15.3%
Op. Margin -188.3% ↘
ROIC -192.6% ↘
FCF / Share $-0.93 ↗
Trailing P/E —
Price / Book 21.9x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

3-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.55M
↑ +15.3% —
Net Income Profit after all expenses
$-25.32M
↓ -27.2% —
Operating Margin Operating profit as % of sales
-188.3%
↓ -11.1% 0th
FCF / Share Free cash flow per share
$-0.93
↑ +90.7% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
1
Returns
3
Financial Health
3
Cash Quality ↓
61

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 3 years · 11 quarters